1/143
stopped at slide 73
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
autoimmune hemolytic anemia
antibodies directed against a person’s own RBCs cause them to lyse
autoimmune hemolytic anemia pathophys
acquired destructive disorder in which IgG autoantibody is formed that binds to RBC membrane protein
autoimmune hemolytic anemia causes
usually idiopathic, can be infective, autoimmune, pregnancy, lymphoproliferative, immunodeficiency
autoimmune hemolytic anemia diagnosis requirement
must distinguish from drug induced hemolytic anemia
autoimmune hemolytic anemia CP/PE
anemia of RAPID onset, fatigue, dyspnea, jaundice, splenomegaly
maybe angina pectoris, hepatomegaly
autoimmune hemolytic anemia dx labs
low hgb, haptoglobin
high reticulocytes, indirect bilirubin, LDH
positive coombs test
coombs test
detects antibodies that attack red blood cells
haptoglobin
binds free hemoglobin and prevents toxicity, acute phase protein, would be low in hemolytic anemia
autoimmune hemolytic anemia medications tx
1st line - predisone 1-2mg/kg/day for several weeks with slow taper
rituximab IV x4 weeks, danazol, folic acid
autoimmune hemolytic anemia non meds tx
packed cells (hard to match, don’t survive well), plasmapheresis, splenectomy, treat underlying condition
autoimmune hemolytic anemia pt ed
hematology referral, likely to relapse, prognosis is good long term
immune thrombocytopenic purpura
autoimmune condition with pathogenic antibodies binding platelets and accelerating their clearance from circulation
immune thrombocytopenic purpura populations
(MC) kids - follows infection
adults - underlying disorder triggers it
immune thrombocytopenic purpura categories
primary idiopathic and secondary
secondary immune thrombocytopenic purpura causes
many autoimmune conditions, MMR vax, h. pylori, HIV, HCV, CMV, VZV, covid
platelet lifespan
1 week
immune thrombocytopenic purpura patho
immune mediated destruction of platelets
antiplatelet ab targets some glycoproteins on platelet membrane
immune thrombocytopenic purpura CP/PE
bruising, epistaxis, petechiae, bleeding gums
maybe mucocutaneous bleeding (plt <10-20)
immune thrombocytopenic purpura dx
CBC with low plt, all else normal
evaluate for secondary causes (viruses, etc)
immune thrombocytopenic purpura tx threshold
plt <25-30 or significant bleeding
immune thrombocytopenic purpura tx
prednisone 1 mg/kg x10-14d then taper
immune thrombocytopenic purpura alternative tx
IVIG 1-2g/kg IV - EXPENSIVE
plt transfusions, rituximab
immune thrombocytopenic purpura outpatient tx indication
no significant bleeding/signs of impending bleeding, plt >5
immune thrombocytopenic purpura inpatient tx indication
bleeding, plt <5
immune thrombocytopenic purpura pt edu
treat underlying infxn, good response to steroids, hematology referral, BE CAUTIOUS
pernicious anemia
rare autoimmune disorder with fundic glands with achlorhydria (little to no HCl prod), decreased IF secretion, and B12 malabsorption
pernicious anemia pathophys
autoab target IF and gastric parietal cells
pernicious anemia population
northern europeans, mostly 70-80 y/o, MC in pts with other autoimmune diseases
pernicious anemia CP/PE
fatigue, lightheadedness, pallor, neuro sx, SOB, glossitis, muscle wasting, weight loss
pernicious anemia dx
CBC w/macrocytic anemia (hgb <4), anti IF ab
low B12
high MMA
pernicious anemia gastric biopsy results
atrophy of all layers, loss of glands, absence of parietal/chief cells, maybe h. pylori hx
pernicious anemia screenings
EGD/colonoscopies (3x risk of GI malignancy)
pernicious anemia tx
B12 supplement, usually lifelong
diet mods
pernicious anemia pt edu
elevated risk of gastric cancer
sx: worsening heartburn, bloody/black stool, unexplained weight loss, decreased appetite
pernicious anemia referral
GI for EGD/colonoscopy
what can be transfused
whole blood, packed cells, platelets, FFP, cryoprecipitate
packed cells transfusion indication
hgb <8 in cardiopulmonary pts
hgb <7 all others
packed cells transfusion cautions
volume, speed, consider special orders
packed cells transfusion benefit
1 decimal point bump in hgb
type and hold
blood type and put in file
type and cross
patient needs blood so pt’s blood is tested and cross tested for matching
type and cross length of accuracy
72 hours
type and hold length of accuracy
30 days
expiration time for blood products
4 hours
special transfusion orders
leukocyte poor, irradiated, CMV negative
platelet transfusion indication
if getting invasive procedure - <50
normal pts - <10
priority transfusion - <5
platelet transfusion cautions
truly necessary?
more transfusions = more sensitized
HLA match
human leukocyte antigen matching
identifying compatible tissue types between a donor and recipient
FFP transfusion indications
factor deficiencies, liver disease
FFP transfusion contraindications
to reverse warfarin
cryoprecipitate transfusion indication
fibrinogen disorders, von willebrand disease (VWD), disseminated intravascular coagulation (DIC), uremic bleeding
transfusion reaction
adverse event that can occur during or after blood product transfusion, more common with platelets
transfusion reaction common types
allergic, febrile nonhemolytic transfusion reaction (FNHTR), transfusion associated circulatory overload (TACO)
febrile nonhemolytic transfusion reaction
cytokine release from wBC in unit
chills, rigor, fever
febrile nonhemolytic transfusion tx
acetaminophen, stop transfusion
allergic transfusion reaction
plasma from donor reacts with pre-existing IgE ab
urticaria
allergic transfusion reaction tx
benadryl, continue transfusion
uremic bleeding populations
renal/dialysis pts
anaphylactic transfusion reaction
product contains substance to which the pt is allergic
dyspnea, coughing, N/V, hypotension, respiratory arrest
anaphylactic transfusion reaction tx
stop transfusion ASAP, epi, steroids
acute hemolytic transfusion reaction
ABO mismatch
hypotension, tachypnea, tachycardia, fever, chills, chest/flank pain
acute hemolytic transfusion reaction tx
stop transfusion ASAP, IV fluids
not really transfusion reactions
fluid overload, hypothermia, electrolyte issues, iron overload
transfusion associated circulatory overload
respiratory distress, evidence of pulmonary edema, elevated BNP, other unexplained cards changes
transfusion associated circulatory overload population
CHF patients and increased transfusion
transfusion associated circulatory overload tx
oxygen, diuresis, ventilatory support
transfusion related acute lung injury
MC with platelets
hypoxia, bilateral infiltrates, some with fever/hypotension
transfusion related acute lung injury tx
stop transfusion, supportive care
progression of transfusion reactions over time
anaphylaxis → allergic → acute hemolytic tfn rxn → febrile non hemolytic tfn rxn → tfn related acute lung injury
calcium citrate in blood consequence
numbness/tingling around mouth
hemochromatosis
autosomal recessive disorder leading to iron overload
who to call with transfusion reaction
lab/blood bank
hemochromatosis genes
MC HFE gene homozygous for C282Y mutation
homozygote C282Y hemochromotosis population
up to 50% devel iron overload, usually men since women rid iron with menses, typically over 30 y/o
hemochromatosis pathophys
HFE protein plays role in which duodenal crypt cells sense iron body stores leading to increased iron absorption from duodenum, decreased synthesis/expression of hepcidin, iron accumulates
hemochromatosis iron accumulation locations
liver, pancreas, heart, adrenal glands, testes, pituitary gland, kidneys
hemochromatosis CP/PE
typically age 50+, fatigue, arthralgia, arthropathy, hepatomegaly, bronze skin, cardiomegaly, diabetes, ED, jaundiced especially in eyes
vital sign interval for transfusion
time 0, 15 mins, and at end
hemochromatosis dx labs
mildly abnormal liver tests
high iron, ferritin, % saturation
low TIBC
positive HFE mutation
hemochromatosis dx non labs
MRI, liver biopsy for cirrhosis
hemochromatosis tx
phlebotomy, supportive care to damaged organs, liver transplant, chelation (?) with deferoxamine
hemochromatosis phlebotomy tips
1 unit of blood = 250mg Fe, need to remove 25g
done weekly x1-2 years or less often for maintenence
PPI can reduce iron more
hemochromatosis pt edu
avoid iron rich food, screen family members
hemoglobin A
normal adult hemoglobin, tetramer of 2 alpha globin chains and 2 beta globin chains
95-98% of circulating hgb
hemoglobin A2
2-3% of circulating hgb
hemoglobin F
50-80% in newborn
8% in 6 month old
0.8-2% of adults
hemoglobin S
not normally present, can indicate sickle cell
sickle cell disease
inherited RBC disorders that cause RBCs to become misshapen and break down
autosomal recessive disorder with hgb SS leading to chronic hemolytic anemia
sickle cell anemia gene
homozygous for hgb S
sickle cell trait gene
heterozygous for hgb S
sickle cell trait
benign carrier state of SCD, usually don’t show manifestations of disease
theoretically protective against malaria due to RBC shape
sickle cell disease mutation causes…?
hfb molecule stacks and forms polymer when deoxygenated and RBCs become rigid
RBC changes in sickle cell disease
membrane changes, interaction with WBC, hemolysis, nitric oxide depletion, release of inflammatory proteins, coagulation
hemochromatosis liver transplant benefit
previous liver is reason for disease due to lack of hepcidin so new liver means very low likelihood of recurrence
sickle cell disease severity
varies a lot
hgb F causes antisickling
alpha thalassemia decreases severity
sickle cell disease population
8% of Black americans
homozygous sickle cell disease prognosis
life expectancy <50, very morbid disease manifests as sickle cell crisis
sickle cell disease CP/PE
chronically ill appearing, hemolytic anemia, jaundice, pigment gallstones, poorly healing skin ulcers over tibia, EXTREME PAIN, hepatomegaly, maybe splenomegaly, cardiomegaly
hemochromatosis screening
unexplained liver disease, chondrocalcinosis, ED, T1D
sickle cell crisis types
veno occlusive, aplastic, sequestration, hyperhemolytic